Study Title and Description
Effect of Raloxifene on all-cause mortality.
Key Questions Addressed
|2||Key Question 2. In adult women without preexisting breast cancer, what is the effectiveness and comparative effectiveness of medications to reduce risk for primary breast cancer on improvement in short- and long-term health outcomes, including invasive breast cancer, noninvasive breast cancer (including ductal carcinoma in situ), breast cancer mortality, all-cause mortality, and other beneficial outcomes (such as reduced fractures caused by certain medications and improved quality of life)? Key Question 2a. Does the effectiveness of risk-reducing medications vary by timing of initiation or duration of use? Key Question 2b. Does the effectiveness of risk-reducing medications persist beyond discontinuation of use?|
Primary Publication Information
|Title||Effect of Raloxifene on all-cause mortality.|
|Author||Grady D., Cauley JA., Stock JL., Cox DA., Mitlak BH., Song J., Cummings SR.|
|Country||University of California, San Francisco, CA 94115, USA. firstname.lastname@example.org|
Pubmed ID: 20399327
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Key Questions 1-4
Results & Comparisons
No Results found.